Quinazolines
This graph shows the total number of publications written about "Quinazolines" by people in the URMC Research Network by year, and whether "Quinazolines" was a major or minor topic of these publication.
Below are the most recent publications written about "Quinazolines" by people in Profiles.
-
Gerich J. DPP-4 inhibitors: what may be the clinical differentiators? Diabetes Res Clin Pract. 2010 Nov; 90(2):131-40.
-
Olmez I, Donahue BR, Butler JS, Huang Y, Rubin P, Xu Y. Clinical outcomes in extracranial tumor sites and unusual toxicities with concurrent whole brain radiation (WBRT) and Erlotinib treatment in patients with non-small cell lung cancer (NSCLC) with brain metastasis. Lung Cancer. 2010 Nov; 70(2):174-9.
-
Braun A, Xu H, Hu F, Kocherlakota P, Siegel D, Chander P, Ungvari Z, Csiszar A, Nedergaard M, Ballabh P. Paucity of pericytes in germinal matrix vasculature of premature infants. J Neurosci. 2007 Oct 31; 27(44):12012-24.
-
Ballabh P, Xu H, Hu F, Braun A, Smith K, Rivera A, Lou N, Ungvari Z, Goldman SA, Csiszar A, Nedergaard M. Angiogenic inhibition reduces germinal matrix hemorrhage. Nat Med. 2007 Apr; 13(4):477-85.
-
Ko J, Ross J, Awad H, Hurwitz H, Klitzman B. The effects of ZD6474, an inhibitor of VEGF signaling, on cutaneous wound healing in mice. J Surg Res. 2005 Dec; 129(2):251-9.
-
Blair ML. Inhibition of renin secretion by intrarenal alpha-adrenoceptor blockade. Am J Physiol. 1981 Jun; 240(6):E682-8.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
|
